Why Linking the MMAS-8 with the WHO Five Dimensions of Adherence Beats a One-Size-Fits-All Approach

In the world of health outcomes, we often talk about what influences patient behavior—why people take their medications, follow lifestyle advice, or show up for appointments. Two powerful models help us understand this: the Social Determinants of Health (SDOH) and the World Health Organization’s Five Dimensions of Adherence. But when it comes to truly understanding and improving medication adherence at the individual level, a more tailored approach is needed—one that leverages tools like the modified Morisky Medication Adherence Scale (MMAS-8) in tandem with the WHO adherence framework.

Let’s break down why this combination is more effective for personalized care—and why SDOH, while crucial, operates best at a different level.

SDOH: The Macro View

Social Determinants of Health provide a bird’s-eye view of what shapes community and population health: income, education, housing, neighborhood safety, and access to quality healthcare. These factors set the stage for what’s possible in a person’s health journey. But they’re broad, structural, and typically beyond the immediate control of healthcare providers or individual patients. They’re essential for designing public health interventions, but not as actionable when you’re trying to understand why John Smith missed his medication for the third day in a row.

WHO’s Five Dimensions of Adherence: The Individual Lens

This is where the WHO’s Five Dimensions of Adherence framework comes in. It breaks down adherence challenges into five modifiable categories:

1. Social and Economic Factors
2. Healthcare System and Provider Relationship
3. Condition-Related Factors
4. Therapy-Related Factors
5. Patient-Related Factors

These dimensions shift the focus to individual experiences—the complexity of their treatment, their trust in providers, personal beliefs, and emotional or cognitive barriers. It’s a comprehensive but flexible structure that gives providers a better understanding of what actually drives adherence behavior at the personal level.

Enter MMAS-8: A Practical Tool for Clinicians

The modified Morisky Medication Adherence Scale (MMAS-8) is an 8-item self-report questionnaire that helps providers assess how adherent a patient is to their medication regimen. It’s quick, easy to administer, and proven to be both reliable and valid across a wide range of conditions.

But here’s the kicker: on its own, mMAS-8 tells you that adherence is a problem—but not why. That’s where the WHO framework shines.

Why the Combination Works

By combining the mMAS-8 with the WHO’s Five Dimensions of Adherence, providers gain a powerful diagnostic and intervention tool:

• MMAS-8 = The “What”
  • Helps quantify adherence.
  • Identifies whether low, medium, or high adherence exists.


• WHO Dimensions = The “Why”
  • Provides a structured way to explore root causes of nonadherence.
  • Supports personalized care planning.

For example, if a patient scores low on the MMAS-8, the next step isn’t to educate them again—it’s to ask why. Is it the cost of medication (social/economic)? Is the treatment too complex (therapy-related)? Do they not believe the medication is helping (patient-related)? This layered approach makes interventions far more effective and targeted.

SDOH vs. WHO + mMAS-8: Complementary, Not Competing

It’s important to understand that this isn’t an either/or situation. SDOH is essential for shaping systemic solutions and policies, but the WHO + MMAS-8 combo is what truly empowers clinicians at the point of care. One is zoomed out; the other is zoomed in. For individualized, real-time decision-making, the WHO framework paired with the MMAS-8 provides nuanced insights that population-level data simply can’t.

Bottom Line: Better Insights, Better Outcomes

Healthcare is moving toward personalization—and so should our models. Integrating the mMAS-8 with the WHO Five Dimensions of Adherence bridges the gap between data and action. It empowers providers to understand each patient’s unique barriers and tailor interventions accordingly.

If your goal is to improve adherence one patient at a time, this approach isn’t just helpful—it’s essential.